NEA Management Company’s Champions Oncology CSBR Stock Holding History

NEA Management Company’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.85M	Hold	1,713,720	–	–	0.56%	17
2025 Q4	$11.8M	Hold	1,713,720	–	–	0.6%	17
2025 Q3	$11.1M	Hold	1,713,720	–	–	0.61%	20
2025 Q2	$12.6M	Hold	1,713,720	–	–	0.95%	18
2025 Q1	$14.9M	Hold	1,713,720	–	–	1.15%	17
2024 Q4	$14.7M	Hold	1,713,720	–	–	0.83%	20
2024 Q3	$8.35M	Hold	1,713,720	–	–	0.45%	29
2024 Q2	$8.86M	Hold	1,713,720	–	–	0.67%	27
2024 Q1	$8.4M	Hold	1,713,720	–	–	0.52%	30
2023 Q4	$9.63M	Hold	1,713,720	–	–	0.64%	30
2023 Q3	$10.6M	Hold	1,713,720	–	–	0.82%	26
2023 Q2	$10.9M	Hold	1,713,720	–	–	0.83%	26
2023 Q1	$6.89M	Hold	1,713,720	–	–	0.48%	30
2022 Q4	$7.73M	Hold	1,713,720	–	–	0.43%	32
2022 Q3	$12.9M	Hold	1,713,720	–	–	0.64%	32
2022 Q2	$13.7M	Hold	1,713,720	–	–	0.7%	30
2022 Q1	$13.9M	Hold	1,713,720	–	–	0.4%	34
2021 Q4	$14.3M	Hold	1,713,720	–	–	0.29%	39
2021 Q3	$17.5M	Hold	1,713,720	–	–	0.21%	43
2021 Q2	$17.6M	Hold	1,713,720	–	–	0.23%	45
2021 Q1	$19.4M	Hold	1,713,720	–	–	0.43%	40
2020 Q4	$18.5M	Hold	1,713,720	–	–	0.49%	37
2020 Q3	$15.9M	Hold	1,713,720	–	–	0.67%	31
2020 Q2	$16.4M	Hold	1,713,720	–	–	0.66%	27
2020 Q1	$12.7M	Buy	1,713,720 +151,220	+10%	+$1.06M	0.66%	24
2019 Q4	$13M	Hold	1,562,500	–	–	0.62%	26
2019 Q3	$8.83M	Hold	1,562,500	–	–	0.73%	27
2019 Q2	$12.2M	Hold	1,562,500	–	–	0.86%	28
2019 Q1	$15.3M	Hold	1,562,500	–	–	0.79%	27
2018 Q4	$12.2M	Hold	1,562,500	–	–	0.48%	30
2018 Q3	$27.3M	Hold	1,562,500	–	–	1.18%	20
2018 Q2	$9.91M	Hold	1,562,500	–	–	0.46%	29
2018 Q1	$5.69M	Hold	1,562,500	–	–	0.25%	39
2017 Q4	$6.06M	Hold	1,562,500	–	–	0.25%	35
2017 Q3	$5.73M	Hold	1,562,500	–	–	0.2%	34
2017 Q2	$4.02M	Hold	1,562,500	–	–	0.15%	35
2017 Q1	$4.95M	Hold	1,562,500	–	–	0.17%	31
2016 Q4	$3.95M	Hold	1,562,500	–	–	0.16%	30
2016 Q3	$2.63M	Hold	1,562,500	–	–	0.12%	31
2016 Q2	$3.36M	Hold	1,562,500	–	–	0.17%	32
2016 Q1	$5.69M	Hold	1,562,500	–	–	0.38%	27
2015 Q4	$5.58M	Hold	1,562,500	–	–	0.36%	25
2015 Q3	$8.36M	Buy	+1,562,500	New	+$10.2M	0.55%	21

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

NEA Management Company's CSBR Position: Q1 2026 in Review

NEA Management Company held its Champions Oncology (CSBR) position steady in Q1 2026 at 1,713,720 shares worth $9.85M. The position accounts for 0.56% of the portfolio, ranked #17.

NEA Management Company first reported a position in CSBR in Q3 2015 and has held it in 43 quarters since. The position peaked at $27.3M in Q3 2018. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

NEA Management Company held 1,713,720 shares of Champions Oncology worth $9.85M as of Q1 2026.
NEA Management Company left its Champions Oncology share count unchanged in Q1 2026.
Champions Oncology made up 0.56% of NEA Management Company's portfolio in Q1 2026, its #17 holding.
NEA Management Company first reported a position in Champions Oncology in Q3 2015 and has held it in 43 quarters since.
NEA Management Company's Champions Oncology position peaked at $27.3M in Q3 2018.
25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.